NEW YORK (GenomeWeb) – The University of Manchester is collaborating with UK-based diagnostics firm Abcodia to identify protein biomarkers for risk stratification and early detection of lung cancer.
The effort is one of a series of biomarker development projects the university will run out of the Stoller Biomarker Discovery Centre that it plans to open next year supported by £17 million ($27 million) in funding largely from the UK's Medical Research Council.